Assure the efficacy and safety of the used synthetic product: CDSCO panel advises Sun Pharma for Liraglutide Injection.

Published Date: 28 Jul 2023

New Delhi: Rejecting Sun Pharma's request for a waiver of clinical trial requirements for the glucagon-like peptide-1 analog Liraglutide.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot